Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Completed Journey
Companies On The Road
Follow The Artist
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Completed Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
2021 Cell & Gene Therapy Report
2021 Monoclonal Antibody & Recombinant Protein Market Report
2022 Sterile Drug Market Report
2022 API Market Report
2022 OSD Market Report
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Antibody
24 Articles Available
Can't find what you're looking for? Try our
advanced search
.
Anti-Idiotype Antibodies
Rapid Supply of Anti-Idiotype Antibodies Facilitates Preclinical and Clinical Antibody-Based Drug Development
PAO-01-23-CL-01
Artificial Intelligence in Antibody Design
Accelerated and Cost-Effective Antibody Design Using Artificial Intelligence
PAO-11-022-CL-15
Recombinant Antibodies
Taking a Customer-Focused Approach to Custom Antibody Development and Manufacturing
PAO-04-022-CL-01
Oncology Collaboration
Tegmine Therapeutics Announces Collaboration with Alloy Therapeutics to Advance Solid Tumor Treatment
PR-M04-22-03
COVID-19 Prevention
AstraZeneca to Supply Canada with 100,000 Doses of Evusheld, a Long-Acting Antibody Combination for the Prevention of COVID-19
PR-M02-22-21
Bispecific Antibodies
A Small Biotech with Two Complex Bispecific Antibody Candidates Benefits from Lonza’s Blend of Expertise and Flexibility
PAO-12-21-CL-01
FDA Authorization
Babson Diagnostics Receives FDA Emergency Use Authorization for its SARS-CoV-2 IgG Antibody Test
PR-M11-20-025
Antibodies
Lilly's Neutralizing Antibody Bamlanivimab (LY-CoV555) Receives FDA Emergency Use Authorization for the Treatment of Recently Diagnosed COVID-19
PR-M11-20-023
Antibodies
Twist Bioscience Announces Positive Preclinical Data for SARS-CoV-2 Antibodies
PR-M11-20-022
M&A
AbCellera Expands Technology Stack with Acquisition of Trianni for $90 Million
PR-M11-20-018
FDA Antibody Tests
FDA Provides Promised Transparency for Antibody Tests
COVID-19 Antibody Testing
Roche's Highly Accurate Antibody Test for COVID-19 Goes Live at More than 20 Initial Lab Sites in the U.S.
PR-M05-20-NI-035
Series B Financing
Orum Therapeutics Announces $30 Million Series B Financing to Advance Cell-Penetrating, Cell-Specific Antibody Technology for Novel Therapeutics
PR-M07-19-NI-052
Intellectual Property
Compugen Expands Intellectual Property Portfolio for COM701 with New U.S. Patent Covering Combination Use with anti-PD-1 Antibody
PR-M07-19-NI-051
Clinical Trials
Arch Oncology Announces First Patient Dosed in Phase 1 Clinical Trial of AO-176, an Anti-CD47 Antibody with a Best-in-Class Profile
PR-M02-19-NI-012
Innovation
A new PD-L1 BOND Ready-to-Use antibody, providing you with the freedom and flexibility to develop the tests you need
PR-M11-18-NI-050
FDA Clearance
Inova Diagnostics Receives FDA Clearance for Test to Detect Antibodies to HMGCR
PR-M09-18-NI-031
Clinical Trial
BeiGene Initiates New Phase 3 Trial of Anti-PD-1 Antibody Tislelizumab Combined with Chemotherapy as First-line Treatment for Patients with Advanced Squamous Non-Small Cell Lung Cancer in China
PR-M08-18-NI-115
Antibody Treatment
BioArctic Obtains Exclusive Rights to Develop Antibody Treatments for Alzheimer's Disease from a Research Project Jointly Owned with Eisai
PR-M08-18-NI-090
Antibody Therapeutic Discovery
Biocompare Launches Antibody Therapeutic Discovery and Development Content Hub
PR-M08-18-NI-063
Drug Discovery
Could a Bispecific Antibody Be A Functional Cure for AIDS?
PAO-M06-18-NI-015
Strategic Collaboration
Compugen, MedImmune to Collaborate on Bi- and Multi-Specific Antibodies
PAO-M04-18-NI-007
Partnership
Amgen and CytomX Therapeutics Collaborate on the Development of Bispecific Antibodies
PAO-M10-17-NI-018
License
WuXi Licenses Ligand Clinical Stage Antibody
PAO-M08-17-NI-029
